ManRos Therapeutics

Founded by Dr Meijer, ManRos Therapeutics is a biotechnology company specialising in the clinical development of kinase inhibitors.
The recent clinical trial conducted on roscovitine, as a therapeutic indication for cystic fibrosis, provided ManRos with real expertise in this R&D sector.
Today, research work is refocused on optimising a new "drug candidate", a patentable molecule derived from roscovitine.